GB0300881D0 - Therapeutic treatment - Google Patents
Therapeutic treatmentInfo
- Publication number
- GB0300881D0 GB0300881D0 GBGB0300881.0A GB0300881A GB0300881D0 GB 0300881 D0 GB0300881 D0 GB 0300881D0 GB 0300881 A GB0300881 A GB 0300881A GB 0300881 D0 GB0300881 D0 GB 0300881D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic treatment
- therapeutic
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4648—Bacterial antigens
- A61K39/464819—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0300881.0A GB0300881D0 (en) | 2003-01-15 | 2003-01-15 | Therapeutic treatment |
PCT/GB2004/000114 WO2004062559A2 (en) | 2003-01-15 | 2004-01-14 | Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0300881.0A GB0300881D0 (en) | 2003-01-15 | 2003-01-15 | Therapeutic treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0300881D0 true GB0300881D0 (en) | 2003-02-12 |
Family
ID=9951177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0300881.0A Ceased GB0300881D0 (en) | 2003-01-15 | 2003-01-15 | Therapeutic treatment |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0300881D0 (en) |
WO (1) | WO2004062559A2 (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL84167A (en) * | 1986-10-24 | 1991-04-15 | Southern Res Inst | Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation |
US6013258A (en) * | 1997-10-09 | 2000-01-11 | Zycos Inc. | Immunogenic peptides from the HPV E7 protein |
WO2001039800A2 (en) * | 1999-12-06 | 2001-06-07 | The Board Of Trustees Of The University Of Arkansas | Controlled delivery of antigens |
DE60121925T2 (en) * | 2000-03-22 | 2007-03-01 | The Secretary Of State For Defence, Salisbury | MEDICINAL PRODUCT FOR ADMINISTRATION ON MICE |
US6565888B1 (en) * | 2000-08-23 | 2003-05-20 | Alkermes Controlled Therapeutics, Inc. | Methods and compositions for the targeted delivery of biologically active agents |
CN101428006A (en) * | 2000-09-28 | 2009-05-13 | 诺华疫苗和诊断公司 | Microparticle compositions and methods for the manufacture thereof |
CA2439111A1 (en) * | 2001-04-05 | 2002-10-17 | Chiron Corporation | Mucosal boosting following parenteral priming |
-
2003
- 2003-01-15 GB GBGB0300881.0A patent/GB0300881D0/en not_active Ceased
-
2004
- 2004-01-14 WO PCT/GB2004/000114 patent/WO2004062559A2/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO2004062559A2 (en) | 2004-07-29 |
WO2004062559A3 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0316912D0 (en) | Therapeutic treatment | |
GB0201850D0 (en) | Therapeutic treatment | |
GB0216321D0 (en) | Therapeutic treatment | |
GB0320806D0 (en) | Therapeutic treatment | |
HK1078784A1 (en) | Therapeutic treatment | |
GB0223367D0 (en) | Therapeutic treatment | |
GB0329275D0 (en) | Therapeutic treatment | |
GB0210464D0 (en) | Therapeutic treatment | |
GB0307863D0 (en) | Therapeutic treatment | |
GB0313772D0 (en) | Therapeutic treatment | |
GB0300428D0 (en) | Medical treatment | |
GB0327493D0 (en) | Treatment medicament | |
GB0306165D0 (en) | Medical treatment | |
GB0318323D0 (en) | Therapeutic treatment | |
GB0321233D0 (en) | Therapeutic treatment | |
GB0318552D0 (en) | Therapeutic treatment | |
GB0321235D0 (en) | Therapeutic treatment | |
GB0300881D0 (en) | Therapeutic treatment | |
GB0321650D0 (en) | Therapeutic treatment | |
GB0322000D0 (en) | Therapeutic treatment | |
GB0321234D0 (en) | Therapeutic treatment | |
GB0321649D0 (en) | Therapeutic treatment | |
GB0321236D0 (en) | Therapeutic treatment | |
SI1553950T1 (en) | Therapeutic treatment | |
GB0207138D0 (en) | Novel therapeutic treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |